Scandinavian ChemoTech: Green light for protocol amendment - Redeye

Redeye provides its comments on Scandinavian ChemoTech’s press release from earlier today. The company announced that the ethics committee at the University Hospital in Jodhpur had approved the study protocol amendment, which means that tumour-specific electroporation (TSE) will be used in earlier, curative stages of treatment.

Länk till analysen i sin helhet: https://www.redeye.se/research/972677/scandinavian-chemotech-green-light-for-protocol-amendment?utm_source=finwire&utm_medium=RSS